Denver, CO (PRWEB) September 18, 2007
LegalView.com, your complete source for everything legal on the web, would like to announce that readers can now find a wealth of important information regarding two prescription drugs that have been shown to be potentially hazardous to patients, Risperdal and Dostinex. Each of these drugs have been linked to potentially life-threatening side-effects, of which all patients should be aware. By consulting LegalView's Risperdal and Dostinex Information portals, at risperdal.legalview.com and dostinex.legalview.com respectively, readers can gain valuable information about the potential negative side effects of these two drugs.
Risperdal is a prescription medication for the treatment of schizophrenia. It is also used for the short-term treatment of mania associated with bipolar disorder. Risperdal is in a class of medications called atypical anti-psychotics, which differ from other anti-psychotics in that they work by muting the impact of dopamine and serotonin, two of the brain's key chemical messengers. Some concern has arisen over Risperdal, as it appears the drug may be responsible for an increased chance of death in elderly persons. Elderly patients treated with atypical anti-psychotics, such as Risperdal, for dementia had a higher chance for death than patients who did not take the medicine, according to the Food and Drug Administration (FDA). Risperdal has also been connected in some patients with the onset of a life-threatening nervous system problem called neuroleptic malignant syndrome (NMS). Anyone who has experienced these symptoms should consult their physician as soon as possible. For more information about the drug, or to be put in touch with a Risperdal law firm, consult LegalView's Risperdal Information portal.
Dostinex is a prescription medication used to treat certain hormone problems involving excess prolactin. In addition, this drug may also be used to treat Parkinson's disease in some cases, treat prolactin-producing tumors and to adjust various hormone levels in certain ovarian diseases. Side effects that should also be reported promptly can include mental or mood changes, fainting, swelling of feet or ankles, breast pain, menstrual changes, vision problems. In addition to these side effects, in two studies published in the New England Journal of Medicine on January 4, 2007, Dostinex was implicated along with pergolide in causing valvular heart disease in some patients. As a result of this, the FDA removed pergolide from the U.S. market on March 29, 2007. Dostinex is approved in the U.S. for the treatment of hyperprolactinemic disorders (conditions in which there are elevated levels of prolactin in the blood). Dostinex is not usually prescribed for the treatment of Parkinson's disease, however, any patients who have received Dostinex as a treatment for Parkinson's should consult with their physician as to whether the dosage of the drug they received may contribute to valvular heart disease. For more information, or to contact an experienced Dostinex attorney readers should visit the Dostinex information portal.
The Dostinex and Risperdal portals are just part of LegalView's collection of free, comprehensive information on the legal issues important to Americans. Readers may also be interested in news, statistics, research and legal information regarding a brain injury attorney, a mesothelioma lawyer, a birth injury law firm or a defective airbag attorney. On all of these sites and others in LegalView's family of free informational Web portals, visitors can find original articles explaining the issue in plain language; links to legal resources; glossaries of medical terms, where appropriate; government warnings and releases; and much more. And if you believe you may have a lawsuit on these topics or others, LegalView offers visitors a way to connect with expert attorneys in your area who can evaluate your case for no charge.
LegalView.com is a free service to the public, brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of highly respected national law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's distinguished sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.legalview.com/.